FR2786501B1 - PROTEINE PARTENAIRE DE LA TOPOISOMERASE IIIa HUMAINE - Google Patents

PROTEINE PARTENAIRE DE LA TOPOISOMERASE IIIa HUMAINE

Info

Publication number
FR2786501B1
FR2786501B1 FR9815081A FR9815081A FR2786501B1 FR 2786501 B1 FR2786501 B1 FR 2786501B1 FR 9815081 A FR9815081 A FR 9815081A FR 9815081 A FR9815081 A FR 9815081A FR 2786501 B1 FR2786501 B1 FR 2786501B1
Authority
FR
France
Prior art keywords
protein partner
human topoisomerase
topoisomerase iiia
iiia
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9815081A
Other languages
English (en)
Other versions
FR2786501A1 (fr
Inventor
Alain Fournier
Helene Goulaouic
Jean Francois Riou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9815081A priority Critical patent/FR2786501B1/fr
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Priority to CA002353304A priority patent/CA2353304A1/fr
Priority to AU13917/00A priority patent/AU776928B2/en
Priority to EP99973067A priority patent/EP1135497A1/fr
Priority to PCT/FR1999/002952 priority patent/WO2000032768A1/fr
Priority to US09/856,930 priority patent/US6706514B1/en
Priority to JP2000585399A priority patent/JP2002531087A/ja
Publication of FR2786501A1 publication Critical patent/FR2786501A1/fr
Application granted granted Critical
Publication of FR2786501B1 publication Critical patent/FR2786501B1/fr
Priority to US10/767,294 priority patent/US20040152162A1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90Isomerases (5.)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR9815081A 1998-11-30 1998-11-30 PROTEINE PARTENAIRE DE LA TOPOISOMERASE IIIa HUMAINE Expired - Fee Related FR2786501B1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR9815081A FR2786501B1 (fr) 1998-11-30 1998-11-30 PROTEINE PARTENAIRE DE LA TOPOISOMERASE IIIa HUMAINE
AU13917/00A AU776928B2 (en) 1998-11-30 1999-11-29 Polypeptides capable of interacting with the human topoisomerase III alpha
EP99973067A EP1135497A1 (fr) 1998-11-30 1999-11-29 Polypeptides capables d'interagir avec la topoisomerase iii alpha humaine
PCT/FR1999/002952 WO2000032768A1 (fr) 1998-11-30 1999-11-29 Polypeptides capables d'interagir avec la topoisomerase iii alpha humaine
CA002353304A CA2353304A1 (fr) 1998-11-30 1999-11-29 Polypeptides capables d'interagir avec la topoisomerase iii alpha humaine
US09/856,930 US6706514B1 (en) 1998-11-30 1999-11-29 Polypeptides capable of interacting with the human topoisomerase IIIα
JP2000585399A JP2002531087A (ja) 1998-11-30 1999-11-29 ヒトのトポイソメラーゼIIIαと相互作用し得るポリペプチド
US10/767,294 US20040152162A1 (en) 1998-11-30 2004-01-29 Polypeptides capable of interacting with human topoisomerase III alpha

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9815081A FR2786501B1 (fr) 1998-11-30 1998-11-30 PROTEINE PARTENAIRE DE LA TOPOISOMERASE IIIa HUMAINE

Publications (2)

Publication Number Publication Date
FR2786501A1 FR2786501A1 (fr) 2000-06-02
FR2786501B1 true FR2786501B1 (fr) 2003-02-07

Family

ID=9533377

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9815081A Expired - Fee Related FR2786501B1 (fr) 1998-11-30 1998-11-30 PROTEINE PARTENAIRE DE LA TOPOISOMERASE IIIa HUMAINE

Country Status (7)

Country Link
US (2) US6706514B1 (fr)
EP (1) EP1135497A1 (fr)
JP (1) JP2002531087A (fr)
AU (1) AU776928B2 (fr)
CA (1) CA2353304A1 (fr)
FR (1) FR2786501B1 (fr)
WO (1) WO2000032768A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1328658A2 (fr) * 2000-06-22 2003-07-23 San Diego State University Foundation Modulateurs de recombinaison et leurs methodes de production et d'utilisation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763234A (en) 1996-07-25 1998-06-09 Florida Atlantic University Secosteroids, and method for producing same
WO1998046747A2 (fr) * 1997-04-11 1998-10-22 Whitehead Institute For Biomedical Research Genes de la region de non-recombinaison du chromosome y

Also Published As

Publication number Publication date
CA2353304A1 (fr) 2000-06-08
EP1135497A1 (fr) 2001-09-26
FR2786501A1 (fr) 2000-06-02
US6706514B1 (en) 2004-03-16
AU776928B2 (en) 2004-09-23
US20040152162A1 (en) 2004-08-05
AU1391700A (en) 2000-06-19
WO2000032768A1 (fr) 2000-06-08
JP2002531087A (ja) 2002-09-24

Similar Documents

Publication Publication Date Title
PT1032396E (pt) Esterilizacao de glucocorticoesteroides
PT1237827E (pt) Preparacao de acelerador de betao
FR09C0062I2 (fr) Anticorps de la il-1 beta humaine
ID25792A (id) Antibodi-antibodi terhadap cd40 manusia
PT1162973E (pt) Preparacao de cilostazole
BR9901846B1 (pt) artigo descartÁvel de excreÇço corporal.
PT888359E (pt) Derivados de pirimidin-4-ona como pesticida
BR9701466A (pt) Implante de área
DK1011699T3 (da) Galactosidase-modificeret submucosavæv
DE59913141D1 (de) Blutbehandlungsgerät
PT945132E (pt) Composicao de ibuprofeno
DE69931855D1 (de) Hautpräparat
PT1150966E (pt) Metodo de preparacao de 5-cianoftalido
PT1169460E (pt) Preparacao de moleculas biologicamente activas.
PT1100326E (pt) Microcapsulas de libertacao activada por bases
DE69833493D1 (de) Gewebe
ATE258035T1 (de) Wegwerfartikel für menschliche fäkalien
BR9702290A (pt) Ensaio de fator sanguíneo
PT1214302E (pt) 3-fenil-5-alcoxi-1,3,4-oxadiazol-2-onas substituidas e sua utilizacao como inibidores de lipase
DE69941173D1 (de) Wegwerfunterhose
PT928197E (pt) Utilizacao de proteinas como agentes contra doencas de natureza autoimunitaria
ATA6897A (de) Präparation umfassend thiolgruppen-hältige proteine
FR2786501B1 (fr) PROTEINE PARTENAIRE DE LA TOPOISOMERASE IIIa HUMAINE
FR2740344B1 (fr) Application de la proteine gax au traitement de cancers
PT1178984E (pt) Derivados de 1-trifluorometil-4-hidroxi-7-piperidinilamimometilcromano

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse